Physician

Andrew F Mcelroy

According to 2025 Medicare claims, Andrew Mcelroy (NPI: 1467986109) practices interventional pain management (ipm) in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Cape May, NJ. This provider's primary affiliated billing organization is COOPER PHYSICAL MEDICINE & REHABILITATION ASSOCIATES, PC (NPI: 1508808221; TIN: 223137520) and primary practice location at 08210-2138.

Mcelroy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 5,504 HCPCS/CPT codes, and received $322,795 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 495 prescription claims across 183 beneficiaries totaling $5,072 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 29 records totaling $3,176. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,907 to $5,072. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$323K2022 Medicare payment: $51,004 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $146,133 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $322,795 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022186658$51,004
20234251,863$146,133
20245625,504$322,795

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.8K$12K2017 Drug cost: $1,907 (USD; Tot_Drug_Cst)2018 Drug cost: $11,527 (USD; Tot_Drug_Cst)2019 Drug cost: $4,171 (USD; Tot_Drug_Cst)2020 Drug cost: $1,412 (USD; Tot_Drug_Cst)2021 Drug cost: $1,513 (USD; Tot_Drug_Cst)2022 Drug cost: $929 (USD; Tot_Drug_Cst)2023 Drug cost: $3,262 (USD; Tot_Drug_Cst)2024 Drug cost: $5,072 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201717101$1,907
201863164$11,527
20191467$4,171
20201126$1,412
20211458$1,513
20221842$929
202371192$3,262
2024183495$5,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more304304$138
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more381903$111
62323Injection of substance into lower spine canal using imaging guidance178225$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more142158$58
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg84587$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GabapentinGabapentin1093,738$1,280
LidocaineLidocaine17570$685
Duloxetine HclDuloxetine Hcl281,980$449
MethylprednisoloneMethylprednisolone90539$432
CelecoxibCelecoxib311,050$384

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$3,176Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew F. Mcelroy?

Tedicare shows public-source Medicare data for Andrew F. Mcelroy (NPI 1467986109), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew F. Mcelroy have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew F. Mcelroy?

Andrew F. Mcelroy is linked to COOPER PHYSICAL MEDICINE & REHABILITATION ASSOCIATES, PC (billing NPI 1508808221) in the available physician profile data.

Does Andrew F. Mcelroy have Open Payments data?

Andrew F. Mcelroy has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.